Skip to main content
. 2021 May 14;70(3):1–26. doi: 10.15585/mmwr.ss7003a1

TABLE 2. Estimated proportion of adults aged ≥19 years who ever received pneumococcal vaccination,* by increased-risk status and race/ethnicity§ National Health Interview Survey, United States, 2018.

Characteristic Sample size % (95% CI) Simple difference from 2017
19–64 yrs at increased risk
Overall
5,851
23.3 (22.0–24.6)
−1.2
White
4,048
23.6 (22.1–25.2)
−1.3
Black
696
25.7 (21.8–30.0)
3.1
Hispanic
656
18.5 (15.2–22.4)
−4.5
Asian
192
25.0 (17.3–34.5)
1.7
Other
259
25.8 (19.3–33.5)
−6.5
≥65 yrs
Overall
7,064
69.0 (67.570.4)
−0.1
White
5,434
72.6 (71.1–74.0)
−0.6
Black
706
59.8 (54.7–64.6)
2.5
Hispanic
509
54.3 (49.2–59.2)
3.2
Asian
263
55.0 (47.4–62.4)
−0.6
Other
152
66.1 (55.8–75.1)
4.8
19–64 yrs at increased risk, at least 2 doses**
5,733
7.5 (6.78.4)
NA
≥65 yrs, at least 2 doses** 6,669 32.3 (30.833.9) NA

Abbreviations: CI = confidence interval; NA = not available.

* Respondents were asked if they had ever had a pneumonia shot.

Adults were categorized as being at increased risk for pneumococcal disease if they had ever been told by a doctor or other health professional that they had 1) diabetes, emphysema, chronic obstructive pulmonary disease, coronary heart disease, angina, heart attack, or other heart condition; 2) a diagnosis of cancer during the previous 12 months (excluding nonmelanoma skin cancer); 3) ever been told by a doctor or other health professional that they had lymphoma, leukemia, or blood cancer; 4) been told by a doctor or other health professional that they had chronic bronchitis or weak or failing kidneys during the preceding 12 months; 5) an asthma episode or attack during the preceding 12 months; or 6) were current smokers.

§ Persons identified as White, Black, Asian, or other race are non-Hispanic. Persons identified as Hispanic might be of any race. “Other” includes American Indian/Alaska Native persons and persons who identified multiple races. The five racial/ethnic categories are mutually exclusive.

p<0.05 by t–test for comparisons with non-Hispanic White as the reference.

** Respondents were asked if they had ever had a pneumonia shot and, if yes, were asked how many doses were received. There were no questions in the 2018 National Health Interview Survey to ascertain pneumococcal vaccination by type of vaccine (23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine).